{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T04:33:33Z","timestamp":1717734813253},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1097\/md.0000000000007064","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T16:41:24Z","timestamp":1496767284000},"page":"e7064","source":"Crossref","is-referenced-by-count":13,"title":["Relationship of Treg\/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment"],"prefix":"10.1097","volume":"96","author":[{"given":"Xiaoling","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-17-20210309","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"R2-17-20210309","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0016-5085(99)70289-1","article-title":"Direct ex vivo analysis of hepatitis B virus specific CD8+T cells associated with the control of infection","volume":"117","author":"Maini","year":"1999","journal-title":"Gastroenterology"},{"key":"R3-17-20210309","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/egh.09.50","article-title":"Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus","volume":"3","author":"Wang","year":"2009","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R4-17-20210309","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nri1573","article-title":"Immunology of hepatitis B virus and hepatitis C virus infection","volume":"5","author":"Rehermann","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R5-17-20210309","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-8278(03)00126-0","article-title":"Translation of immunological knowledge into better treatments of chronic hepatitis B","volume":"39","author":"Bertoletti","year":"2003","journal-title":"J Hepatol"},{"key":"R6-17-20210309","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20061287","article-title":"Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage","volume":"204","author":"Dunn","year":"2007","journal-title":"J Exp Med"},{"key":"R7-17-20210309","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.clim.2006.09.006","article-title":"Increased infiltration of intrahepatic DC subsets closely correlate with viral control and liver injury in immune active pediatric patients with chronic hepatitis B","volume":"122","author":"Zhang","year":"2007","journal-title":"Clin Immunol"},{"key":"R8-17-20210309","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3851\/IMP1508","article-title":"Differential effects of interferon and lamivudine on serum HBV DNA inhibition in patients with chronic hepatitis B","volume":"15","author":"Huang","year":"2010","journal-title":"Antivir Ther"},{"key":"R9-17-20210309","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","article-title":"Naturally arising CD4+regulatory T cells for immunologic self-tolerance and negative control of immune responses","volume":"22","author":"Sakaguchi","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"R10-17-20210309","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.25.022106.141557","article-title":"IL-17 family cytokines and the expanding diversity of effector T cell lineages","volume":"25","author":"Weaver","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"R11-17-20210309","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/jhep.2001.23045","article-title":"Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy","volume":"33","author":"Boni","year":"2001","journal-title":"Hepatology"},{"key":"R12-17-20210309","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells","volume":"441","author":"Bettlli","year":"2006","journal-title":"Nature"},{"key":"R13-17-20210309","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/hep.20649","article-title":"Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection","volume":"41","author":"Stoop","year":"2005","journal-title":"Hepatology"},{"key":"R14-17-20210309","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4049\/jimmunol.177.1.739","article-title":"Circulating and liver resident CD4+CD25+regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B","volume":"177","author":"Xu","year":"2006","journal-title":"J Immunol"},{"key":"R15-17-20210309","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.virol.2006.11.018","article-title":"Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B","volume":"361","author":"Stoop","year":"2007","journal-title":"Virology"},{"key":"R16-17-20210309","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.humimm.2012.01.014","article-title":"Relations of regulatory T cells with hepatitis markers in chronic hepatitis B virus infection","volume":"73","author":"El-Badawy","year":"2012","journal-title":"Hum Immunol"},{"key":"R17-17-20210309","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/cmi.2010.37","article-title":"Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies","volume":"8","author":"Jiang","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"R18-17-20210309","doi-asserted-by":"crossref","first-page":"e13869","DOI":"10.1371\/journal.pone.0013869","article-title":"Decreased ration of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment","volume":"5","author":"Zhang","year":"2010","journal-title":"PLoS One"},{"key":"R19-17-20210309","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10875-009-9328-2","article-title":"Implication of Th17 and Th1 cells in patients with chronic active hepatitis B","volume":"30","author":"Ge","year":"2010","journal-title":"J Clin Immunol"},{"key":"R20-17-20210309","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/hep.23273","article-title":"IL-17-producing CD4+T cells increase with severity of liver damage in patients with chronic hepatitis B","volume":"51","author":"Zhang","year":"2010","journal-title":"Hepatology"},{"key":"R21-17-20210309","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaut.2008.11.001","article-title":"Hepatic IL-17 responses in human and murine primary biliary cirrhosis","volume":"32","author":"Lan","year":"2009","journal-title":"J Autoimmun"},{"key":"R22-17-20210309","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.22680","article-title":"The interleukin-17 pathway is involved in human alcoholic liver disease","volume":"49","author":"Lemmers","year":"2009","journal-title":"Hepatology"},{"key":"R23-17-20210309","doi-asserted-by":"crossref","first-page":"e39307","DOI":"10.1371\/journal.pone.0039307","article-title":"Significance of the balance between regulatory T (Treg)and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"R24-17-20210309","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/jgh.12082","article-title":"Imbalance of interleukin-17-producing CD4 T cells\/regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acute-on-chronic liver failure","volume":"28","author":"Zhang","year":"2013","journal-title":"J Gastroen Heptaol"},{"key":"R25-17-20210309","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11739-012-0867-9","article-title":"Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma","volume":"9","author":"Amedei","year":"2014","journal-title":"Intern Emerg Med"},{"key":"R26-17-20210309","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.diagmicrobio.2013.04.026","article-title":"Changes in the balance between Treg and Th17 cells in patients with chronic hepatitis B","volume":"76","author":"Su","year":"2013","journal-title":"Diagn Micr Infec Dis"},{"key":"R27-17-20210309","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1056\/NEJMoa066422","article-title":"Telbivudine versus lamivudine in patients with chronic hepatitis B","volume":"357","author":"Lai","year":"2007","journal-title":"N Engl J Med"},{"key":"R28-17-20210309","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10096-012-1723-6","article-title":"Lamivudine versus telbivudine in the treatment of chronic hepatitis B: a systematic review and meta-analysis","volume":"32","author":"Jiang","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R29-17-20210309","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2011.04.008","article-title":"Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B","volume":"91","author":"Chen","year":"2011","journal-title":"Antiviral Res"},{"key":"R30-17-20210309","first-page":"646","article-title":"Programmed death-1 (PD-1) and PD-L1 expression during antiviral treatment of chronic hepatitis B","volume":"18","author":"Xie","year":"2010","journal-title":"Chin J Hepatol"},{"key":"R31-17-20210309","first-page":"885","article-title":"The effect of telbivudine on peripheral blood CD4+CD25+ regulatory T cells and its significance in patients with chronic hepatitis B","volume":"16","author":"Pan","year":"2008","journal-title":"Chin J Hepatol"},{"key":"R32-17-20210309","first-page":"13","article-title":"The guideline of prevention and treatment for chronic hepatitis B (2010 version).","volume":"19","year":"2011","journal-title":"Chin J Hepatol"},{"key":"R33-17-20210309","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2567.2007.02691.x","article-title":"Circulating CD4+CD25+regulatory T cells correlate with chronic hepatitis B infection","volume":"123","author":"Guo","year":"2008","journal-title":"Immunology"},{"key":"R34-17-20210309","doi-asserted-by":"crossref","first-page":"e15332","DOI":"10.5812\/hepatmon.15332","article-title":"Dynamic changes of Treg and Th17 cells and related cytokines closely correlate with the virological and biochemical response in chronic hepatitis b patients undergoing nucleos(t)ide analogues treatment","volume":"13","author":"Yu","year":"2013","journal-title":"Hepat Mon"},{"key":"R35-17-20210309","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/intimm\/dxl130","article-title":"Association of CD4+CD25+Foxp3+regulatory T cells with chronic activity and viral clearance in patients with hepatitis B","volume":"19","author":"Yang","year":"2007","journal-title":"Int Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000007064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:51:16Z","timestamp":1620960676000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201706090-00017"}},"subtitle":["A longitudinal observational study"],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":35,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000007064","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}